Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire

BACKGROUND: Patients with poor-risk Waldenström’s macroglobulinemia have suboptimal response and early post-treatment relapse with conventional therapies. Hence, new therapeutic approaches such as allogeneic stem cell transplantation should be evaluated in these patients. DESIGN AND METHODS: We exam...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Garnier, Alice, Robin, Marie, Larosa, Fabrice, Golmard, Jean-Louis, Le Gouill, Steven, Coiteux, Valérie, Tabrizi, Reza, Bulabois, Claude-Eric, Cacheux, Victoria, Kuentz, Mathieu, Dreyfus, Brigitte, Dreger, Peter, Rio, Bernard, Moles-Moreau, Marie-Pierre, Bilger, Karin, Bay, Jacques-Olivier, Leblond, Véronique, Blaise, Didier, Tournilhac, Olivier, Dhédin, Nathalie
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ferrata Storti Foundation 2010
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2878793/
https://ncbi.nlm.nih.gov/pubmed/20081058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.017814
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller